Sarah James
Stock Analyst at Cantor Fitzgerald
(2.53)
# 1,443
Out of 4,412 analysts
138
Total ratings
47.06%
Success rate
-0.42%
Average return
Main Sectors:
28 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HUM Humana | Maintains: Neutral | $391 → $360 | $305.90 | +17.69% | 10 | Apr 25, 2024 | |
AMED Amedisys | Reiterates: Neutral | $101 | $91.79 | +10.03% | 6 | Apr 25, 2024 | |
UNH UnitedHealth Group | Reiterates: Overweight | $591 | $495.35 | +19.31% | 6 | Apr 10, 2024 | |
UHS Universal Health Services | Reiterates: Underweight | $156 | $166.06 | -6.06% | 12 | Apr 10, 2024 | |
THC Tenet Healthcare | Reiterates: Overweight | $104 | $96.13 | +8.19% | 10 | Apr 10, 2024 | |
TBRG TruBridge | Reiterates: Overweight | $24 | $8.04 | +198.51% | 2 | Apr 10, 2024 | |
SGRY Surgery Partners | Reiterates: Overweight | $43 | $24.55 | +75.15% | 6 | Apr 10, 2024 | |
RCM R1 RCM | Reiterates: Overweight | $20 | $11.90 | +68.07% | 3 | Apr 10, 2024 | |
HCAT Health Catalyst | Reiterates: Overweight | $16 | $6.03 | +165.34% | 2 | Apr 10, 2024 | |
HCA HCA Healthcare | Reiterates: Overweight | $335 | $306.69 | +9.23% | 6 | Apr 10, 2024 | |
ELV Elevance Health | Reiterates: Overweight | $580 | $537.26 | +7.96% | 10 | Apr 10, 2024 | |
CVS CVS Health | Reiterates: Overweight | $87 | $67.18 | +29.50% | 6 | Apr 10, 2024 | |
CI Cigna | Reiterates: Overweight | $384 | $354.47 | +8.33% | 9 | Apr 10, 2024 | |
MOH Molina Healthcare | Reiterates: Overweight | $406 | $342.23 | +18.63% | 5 | Apr 4, 2024 | |
CNC Centene | Reiterates: Overweight | $90 | $74.00 | +21.62% | 5 | Apr 4, 2024 | |
LFMD LifeMD | Maintains: Overweight | $9 → $11 | $11.95 | -7.95% | 6 | Mar 12, 2024 | |
DVA DaVita | Initiates: Equal-Weight | $133 | $133.51 | -0.38% | 4 | Mar 6, 2024 | |
ACHC Acadia Healthcare Company | Reiterates: Neutral | $90 | $73.59 | +22.30% | 3 | Mar 5, 2024 | |
DCGO DocGo | Maintains: Overweight | $13 → $11 | $3.61 | +204.71% | 5 | Feb 29, 2024 | |
TDOC Teladoc Health | Initiates: Overweight | $22 | $13.01 | +69.10% | 1 | Feb 29, 2024 | |
PGNY Progyny | Reiterates: Overweight | $48 | $32.04 | +49.81% | 7 | Feb 28, 2024 | |
ACAD ACADIA Pharmaceuticals | Reiterates: Overweight | $42 | $16.71 | +151.35% | 3 | Aug 22, 2023 | |
INNV InnovAge Holding | Maintains: Equal-Weight | $6 → $5 | $3.91 | +27.88% | 2 | Sep 15, 2022 | |
AVAH Aveanna Healthcare Holdings | Maintains: Overweight | $7 → $5 | $2.20 | +127.27% | 2 | Aug 19, 2022 | |
ALHC Alignment Healthcare | Maintains: Overweight | $14 → $21 | $5.21 | +303.07% | 3 | Aug 8, 2022 | |
RDNT RadNet | Initiates: Overweight | n/a | $48.40 | - | 1 | Aug 12, 2021 | |
HSIC Henry Schein | Upgrades: Overweight | n/a | $73.13 | - | 2 | Sep 15, 2017 | |
CYH Community Health Systems | Downgrades: Underweight | n/a | $3.39 | - | 1 | Mar 1, 2017 |
Humana
Apr 25, 2024
Maintains: Neutral
Price Target: $391 → $360
Current: $305.90
Upside: +17.69%
Amedisys
Apr 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $91.79
Upside: +10.03%
UnitedHealth Group
Apr 10, 2024
Reiterates: Overweight
Price Target: $591
Current: $495.35
Upside: +19.31%
Universal Health Services
Apr 10, 2024
Reiterates: Underweight
Price Target: $156
Current: $166.06
Upside: -6.06%
Tenet Healthcare
Apr 10, 2024
Reiterates: Overweight
Price Target: $104
Current: $96.13
Upside: +8.19%
TruBridge
Apr 10, 2024
Reiterates: Overweight
Price Target: $24
Current: $8.04
Upside: +198.51%
Surgery Partners
Apr 10, 2024
Reiterates: Overweight
Price Target: $43
Current: $24.55
Upside: +75.15%
R1 RCM
Apr 10, 2024
Reiterates: Overweight
Price Target: $20
Current: $11.90
Upside: +68.07%
Health Catalyst
Apr 10, 2024
Reiterates: Overweight
Price Target: $16
Current: $6.03
Upside: +165.34%
HCA Healthcare
Apr 10, 2024
Reiterates: Overweight
Price Target: $335
Current: $306.69
Upside: +9.23%
Elevance Health
Apr 10, 2024
Reiterates: Overweight
Price Target: $580
Current: $537.26
Upside: +7.96%
CVS Health
Apr 10, 2024
Reiterates: Overweight
Price Target: $87
Current: $67.18
Upside: +29.50%
Cigna
Apr 10, 2024
Reiterates: Overweight
Price Target: $384
Current: $354.47
Upside: +8.33%
Molina Healthcare
Apr 4, 2024
Reiterates: Overweight
Price Target: $406
Current: $342.23
Upside: +18.63%
Centene
Apr 4, 2024
Reiterates: Overweight
Price Target: $90
Current: $74.00
Upside: +21.62%
LifeMD
Mar 12, 2024
Maintains: Overweight
Price Target: $9 → $11
Current: $11.95
Upside: -7.95%
DaVita
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $133.51
Upside: -0.38%
Acadia Healthcare Company
Mar 5, 2024
Reiterates: Neutral
Price Target: $90
Current: $73.59
Upside: +22.30%
DocGo
Feb 29, 2024
Maintains: Overweight
Price Target: $13 → $11
Current: $3.61
Upside: +204.71%
Teladoc Health
Feb 29, 2024
Initiates: Overweight
Price Target: $22
Current: $13.01
Upside: +69.10%
Progyny
Feb 28, 2024
Reiterates: Overweight
Price Target: $48
Current: $32.04
Upside: +49.81%
ACADIA Pharmaceuticals
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $16.71
Upside: +151.35%
InnovAge Holding
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $3.91
Upside: +27.88%
Aveanna Healthcare Holdings
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $2.20
Upside: +127.27%
Alignment Healthcare
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $5.21
Upside: +303.07%
RadNet
Aug 12, 2021
Initiates: Overweight
Price Target: n/a
Current: $48.40
Upside: -
Henry Schein
Sep 15, 2017
Upgrades: Overweight
Price Target: n/a
Current: $73.13
Upside: -
Community Health Systems
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.39
Upside: -